$194.12 +2.69 (%) Shire Shs Sponsored American Deposit Receipt Repr 3 Shs - NASDAQ

Jul. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. CTI-Baxalta Drug Withdrawn, Removing Potential Incyte Rival

    IBD | Feb. 10, 2016 | 13:50PM EST
  2. Benzinga's Top Initiations

    Benzinga | Feb. 10, 2016 | 09:46AM EST
  3. Benzinga's Volume Movers

    Benzinga | Jan. 13, 2016 | 10:14AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Jan. 12, 2016 | 08:49AM EST
  5. Baxalta OKs Shire Terms

    IBD | Jan. 11, 2016 | 19:29PM EST
  6. Benzinga's M&A Chatter for Monday January 11, 2016

    Benzinga | Jan. 11, 2016 | 18:41PM EST
  7. Baxalta Board Finally Accepts Shire's Takeover Offer

    IBD | Jan. 11, 2016 | 12:24PM EST
  8. Stocks' Early Gains Fade; Fitbit Tumbles; Tesla Reverses Lower

    IBD | Jan. 11, 2016 | 10:34AM EST
  9. Benzinga's M&A Chatter for Thursday January 7, 2016:

    Benzinga | Jan. 7, 2016 | 20:41PM EST
  10. Benzinga's M&A Chatter for Wednesday January 6, 2016

    Benzinga | Jan. 6, 2016 | 19:29PM EST
  11. Baxalta inks cancer drug deal

    IBD | Jan. 4, 2016 | 18:42PM EST
  12. Big Cap 20 Stocks Beaten Up In Global Sell-Off

    IBD | Jan. 4, 2016 | 18:29PM EST
  13. 8 Stocks Moving In Monday's After-Hours Session

    Benzinga | Jan. 4, 2016 | 16:50PM EST
  14. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD | Jan. 4, 2016 | 12:52PM EST
  15. Baxalta Shares Higher Amid Report Of Shire Interest

    Benzinga | Jan. 4, 2016 | 11:02AM EST
  16. The Best Stock Ideas Of December

    Benzinga | Jan. 4, 2016 | 07:46AM EST
  17. Stocks To Watch For January 4, 2016

    Benzinga | Jan. 4, 2016 | 04:25AM EST
  18. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  19. Evercore Partners Lands Advisory Fees On Big Deals

    IBD | Dec. 22, 2015 | 16:22PM EST
  20. Report: Shire Close To Acquiring Baxalta, Cites Company's Revised Cash Offer

    Benzinga | Dec. 22, 2015 | 13:08PM EST
  21. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD | Dec. 18, 2015 | 12:13PM EST
  22. Must Watch Stocks for December 14, 2015

    Benzinga | Dec. 14, 2015 | 04:41AM EST
  23. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 13, 2015 | 19:01PM EST
  24. U.S.-Traded Eurozone Stocks React Mildly To ECB Vote

    IBD | Dec. 3, 2015 | 18:11PM EST
  25. Stocks Wobble After ECB Rate Vote; Avago, Dyax up

    IBD | Dec. 3, 2015 | 11:40AM EST
  26. Pfizer-Allergan A Go Despite New Tax Inversion Rules?

    IBD | Nov. 19, 2015 | 19:05PM EST
  27. Pfizer, Allergan Near Deal Despite Treasury Warning

    IBD | Nov. 19, 2015 | 11:28AM EST
  28. John Paulson Sells Stake in Broadcom, Cuts Cablevision Holding

    GuruFocus | Nov. 18, 2015 | 15:58PM EST
  29. Benzinga's Top Upgrades

    Benzinga | Nov. 17, 2015 | 09:44AM EST
  30. Stock Futures Gather Momentum; Baxalta, Tesla, Paycom Climb

    IBD | Nov. 4, 2015 | 09:17AM EST
  31. Benzinga's M&A Chatter for Monday November 2, 2015

    Benzinga | Nov. 2, 2015 | 20:04PM EST
  32. Shire Buys Orphan-Drug Firm

    IBD | Nov. 2, 2015 | 18:53PM EST
  33. M&A News Fuels More Gains; Celgene, Regeneron Lead Nasdaq 100

    IBD | Nov. 2, 2015 | 13:19PM EST
  34. ConAgra Sells Private Label, Visa Buys Visa Europe

    IBD | Nov. 2, 2015 | 11:13AM EST
  35. Benzinga's Volume Movers

    Benzinga | Nov. 2, 2015 | 10:24AM EST
  36. Shire Buying Rare-Disease Rival Dyax For $5.9 Billion

    IBD | Nov. 2, 2015 | 10:21AM EST
  37. Stocks On Track For Higher Start; ConAgra Jumps On Deal News

    IBD | Nov. 2, 2015 | 09:06AM EST
  38. US Stock Futures Edge Higher Ahead Of Manufacturing Data

    Benzinga | Nov. 2, 2015 | 07:22AM EST
  39. UPDATE: Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio

    Benzinga | Nov. 2, 2015 | 06:02AM EST
  40. Optimism Kicks In, Futures Surge; Alphabet, Amazon, Microsoft Lead

    IBD | Oct. 23, 2015 | 09:08AM EST
  41. Shire Receives FDA CRL for Lifitegrast NDA and Plans to Respond with OPUS-3 Trial

    Benzinga | Oct. 17, 2015 | 07:19AM EST
  42. Benzinga's M&A Chatter for Thursday October 15, 2015

    Benzinga | Oct. 15, 2015 | 18:29PM EST
  43. Benzinga's Top Initiations

    Benzinga | Oct. 14, 2015 | 10:13AM EST
  44. 3 new drugs likely coming

    IBD | Sep. 30, 2015 | 18:51PM EST
  45. Baidu Downgraded; Valeant Soars On Analyst Move

    IBD | Sep. 30, 2015 | 14:16PM EST
  46. 3 Big Drugs Likely To Hit The Market Soon

    IBD | Sep. 30, 2015 | 12:34PM EST
  47. Shire Receives EC Approval for INTUNIV Prolonged Release Tablets as a Non-stimulant ADHD Treatment for Children and Adolescents

    Benzinga | Sep. 21, 2015 | 04:16AM EST
  48. Must Watch Stocks for September 14, 2015

    Benzinga | Sep. 14, 2015 | 05:19AM EST
  49. Benzzinga's Weekend M&A Chatter

    Benzinga | Sep. 13, 2015 | 17:51PM EST
  50. Benzinga's Weekend M&A Chatter

    Benzinga | Aug. 30, 2015 | 20:30PM EST
Trading Center